DFDA

Liver Transplant

Treatment for Acute Hepatitis E

Typical Dosage: Not applicable

Effectiveness
75%
Safety Score
25%
Clinical Trials
1,000
Participants
50K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Not applicable
Time to Effect
Immediate post-procedure
Treatment Duration
Lifelong immunosuppression
Evidence Quality
HIGH
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$15,000
Monitoring:$7,500
Side Effect Mgmt:$7,500
Total Annual:$30,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
ICER
$200,000/QALY
QALYs Gained
6
Outcome-Based Costs
Cost per Responder
$40,000
Liver Transplant Outcomes

for Acute Hepatitis E

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+75%
Common Side Effects
Surgical complications (bleeding, infection)
+15%
Graft rejection
+12%
Immunosuppression-related infections
+30%
Renal dysfunction
+10%

Sources:

nih.gov
easl.eu
who.int

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov